<--- Back to Details
First PageDocument Content
Anatomical pathology / International Classification of Diseases for Oncology / Carcinoma / Squamous-cell carcinoma / Malignant rhabdoid tumour / Metastasis / Cancer / WHO classification of the tumors of the central nervous system / ICD-10 Chapter II: Neoplasms / Medicine / Oncology / Gynaecological cancer
Date: 2015-03-05 10:43:51
Anatomical pathology
International Classification of Diseases for Oncology
Carcinoma
Squamous-cell carcinoma
Malignant rhabdoid tumour
Metastasis
Cancer
WHO classification of the tumors of the central nervous system
ICD-10 Chapter II: Neoplasms
Medicine
Oncology
Gynaecological cancer

Summary of conclusions and recommendations

Add to Reading List

Source URL: www.iarc.fr

Download Document from Source Website

File Size: 176,92 KB

Share Document on Facebook

Similar Documents

#4503 A Small Molecule Glycomimetic Antagonist of E-selectin (GMIPrevents Pancreatic Tumor Metastasis and Offers Improved Efficacy of Chemotherapy Maria M. Steele1, BS, Prakash Radhakrishnan1, PhD, John L. Magnani

DocID: 1vkKU - View Document

Quantitative image-based phenotypes for cancer metastasis systems biology Joel S. Bader, Ph.D. Professor, Biomedical Engineering Johns Hopkins University

DocID: 1vd8y - View Document

A  small  molecule  glycomime.c  antagonist   of  E-­‐selec.n  and  CXCR4  (GMI-­‐1359)   delays  pancrea.c  tumor  metastasis  and   significantly  alters  the

DocID: 1uubq - View Document

Why we focus on Metastasis & Invasion Around 90% of cancer deaths are attributable to invasion and metastasis. Metastasis is the spread of disease from one organ or part to another not directly connected with the primary

DocID: 1sjoH - View Document

Nota de Prensa LA FDA APRUEBA DENOSUMAB PARA LA PREVENCIÓN DE EVENTOS ESQUELÉTICOS EN PACIENTES CON METÁSTASIS ÓSEAS DE TUMORES SÓLIDOS BARCELONA. (nov. 19, 2010) – La FDA ha aprobado denosumab, el primer y

DocID: 1s5nh - View Document